Company / Revenue
TransMedics Group, Inc. Revenue History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$605.5M
FY2025
5-year range
$25.6M / $605.5M
FY2021-FY2025
Trend
+37.1%
vs FY2024
Sector context
#118 of 156
Health Care
What the data says
TransMedics Group, Inc.'s revenue of $605M is lower than 76% of companies in the Health Care sector (FY2025). Revenue has increased for 3 consecutive years, from $26M in FY2022 to $605M in FY2025.
Based on SEC 10-K filings.
$605M in FY2025 with a 5-year CAGR of +91.3%.
Improved from $242M to $605M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +186.9%
- 5-Year CAGR
- +91.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 156This company $605.5M Sector average $19.0B
▼
-96.8% below sector average
Key checks
Key Insights
- TransMedics Group, Inc.'s revenue has grown for 3 consecutive years.
- 5-year CAGR of +91.3%, indicating consistent growth.
- In FY2025, revenue increased 37.1% year-over-year.
- Ranks #118 out of 156 companies in the Health Care sector.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $605.5M | +37.1% |
| FY2024 | $441.5M | +82.7% |
| FY2023 | $241.6M | +842.4% |
| FY2022 | $25.6M | +0.0% |
| FY2021 | $25.6M | +8.6% |
| FY2020 | $23.6M | +81.3% |
| FY2019 | $13.0M | +0.0% |
| FY2018 | $13.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026